Assessment of cerebrospinal fluid levels of serum amyloid P component in patients with Alzheimer's disease

Neuroscience Letters

Volumn 273, Issue 2, 1999, Pages 137-139

  Kimura, M ^a,d   Asada, T ^a   Uno, M ^a   MacHida, N ^b   Kasuya, K ^c   Taniguchi, Y ^c   Fujita, T ^c   Nishiyama, E ^d   Iwamoto, N ^d   Arai, H ^d  

^a National Center of Neurology and Psychiatry   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c Oriental Yeast Co Ltd   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Amyloid P component; Cerebrospinal fluid; Mini Mental State Examination; Soluble amyloid precursor protein; Tau protein

Indexed keywords

SERUM AMYLOID P; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032841151     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00631-X     Document Type: Article

References (16)

1. Arai H., Terajima M., Miura M., Higuchi S., Muramatsu T., Machida N., Seiki H., Takase S., Clark C.M., Lee V.M., Trojanowski J.Q., Sasaki H. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann. Neurol. 38:1995;649-652.
2. Coria F., Castano E., Prelli F., Larrondo-Lillo M., van Duinen S., Shelanski M.L., Fragione B. Isolation and characterization of amyloid P component from Alzheimer's disease and other type of cerebral amyloidosis. Lab. Invest. 58:1988;454-458.
3. Duong T., Pommier E.C., Scheibel A.B. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol. 78:1989;429-437.
4. Hamazaki H. Amyloid P component aggregation of Alzheimer's β-amyloid peptide. Biochem. Biophys. Res. Commun. 211:1995;349-353.
5. Hawkins P.N., Rossor M.N., Gallimore J.R., Miller B., Moore E.G., Pepys M.B. Concentration of serum amyloid P component in the CSF as possible marker of cerebral amyloid deposits in Alzheimer's disease. Biochem. Biophys. Res. Commun. 201:1994;722-726.
6. Hixon J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and clevage with HhaI. J. Lipid. Res. 31:1990;545-548.
7. Kalaria R.N., Golde T.E., Cohen M.L., Younkin S.G. Serum amyloid P in Alzheimer's disease. Implications for dysfunction of the blood-brain barrier. Ann. N.Y. Acad. Sci. 640:1991;145-148.
8. Kimura M., Arai H., Takahashi T., Iwamoto N. Amyloid-P-component-like immunoreactivity in β/A4-immunoreactive deposits in Alzheimer-type dementia brains. J. Neurol. 241:1994;170-174.
9. Lannfelt L., Basun H., Wahlund L.O., Rowe B.A., Wagner S.L. Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat. Med. 1:1995;829-832.
10. Mads N., Hanne O., Bernard J., Karen A.R., Ellen H.N., Sven-Erik S. Increased plasma concentration of serum amyloid p component in centenarians with impaired cognitive performance. Dement. Geriatr. Cogn. Dissord. 9:1998;126-129.
11. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Forces on Alzheimer's disease. Neurology. 34:1984;939-944.
12. Miyazaki K., Hasegawa M., Funahashi K., Ueda M. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature. 362:1993;839-841.
13. Nakamura T., Shoji M., Harigaya Y., Watanabe M., Hosoda K., Cheung T.T., Shaffer L.M., Golde T.E., Younkin L.H., Younkin S.G., Hirai S. Amyloid beta protein levels in cerebrospinal fluid are elevated in early- onset Alzheimer's disease. Ann. Neurol. 36:1994;903-911.
14. Nishiyama N., Iwamoto N., Kimura M., Arai H. Serum amyloid P component level in Alzheimer's disease. Dementia. 7:1996;256-259.
15. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J. Neurol. Neurosurg. 57:1994;416-418.
16. Vanderrmeeren M., Mercken M., Vanmechelen E., Six J., van de Voorde A., Martinm J.J., Cras P. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61:1993;1828-1834.